Implantable devices in the electromagnetic environment  by Santini, Luca et al.
Journal of Arrhythmia 29 (2013) 325–333Contents lists available at ScienceDirectJournal of Arrhythmia1880-42
http://d
Abbre
resynch
AEDs, au
stimula
n Corr
E-mjournal homepage: www.elsevier.com/locate/joaReviewImplantable devices in the electromagnetic environment
Luca Santini a, Giovanni B. Forleo a, Massimo Santini b,n
a PoliclinicoTor Vergata, Department of Internal Medicine, Division of Cardiology, Rome, Italy
b San Filippo Neri Hospital, Cardiovascular Department, Division of Cardiology, Rome, Italya r t i c l e i n f o
Article history:
Received 30 April 2013
Received in revised form
3 June 2013
Accepted 24 June 2013
Available online 30 July 2013
Keywords:
Electromagnetic interference
Pacemaker
ICD
MRI
Mobile phones76/$ - see front matter & 2013 Japanese Hear
x.doi.org/10.1016/j.joa.2013.06.004
viations: CIEDs, cardiovascular implantable ele
ronization therapy; PM, pacemakers; EMI, ele
tomatic external deﬁbrillators; HF, high-frequ
tion
esponding author. Tel.: +39 06 33062294.
ail address: m.santini@rmnet.it (M. Santini).a b s t r a c t
In the last few years we are witnessing a dramatic increase in the number of CIEDs implanted. At the
same time new emitters are constantly entering the marketplace and more and more medical procedures
are based on electromagnetic ﬁelds as well. Therefore, the topic of the interaction of CIEDs with the EMI
is a real, actual and challenging one. In the non-medical environment several types of devices may be
intentional or non-intentional sources of EMI. Most of the studies reported in literature focused on
mobile phones, metal detectors, as well as on headphones or digital players, but many other instruments
and tools may generate electromagnetic ﬁelds. In the medical environment most of the attention is paid
to MRI and recently new PM and MRI conditional ICDs have been developed and launched in the market,
but the risk of interaction is present also with ionizing radiation, electrical nerve stimulation and
electrosurgery. Pacemaker/ICD manufacturers are incorporating state of the art technology to make
implantable devices less susceptible to EMI. However, patients and emitter manufacturers should be
aware that limitations exist and that there is not complete immunity to EMI.
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Since their introduction, at the end of ﬁfties, cardiovascular
implantable devices (CIEDs) have widely expanded in number and
in their functions [1,2]. The dramatic increase in the number
of CIEDs implanted in the last decade is mainly due to the aging
of population and to the expanding indications for both primary
prevention of sudden cardiac death (SCD) and non-pharmaco-
logical treatment of heart failure, following a huge prevalence,
indeed, of implantable cardioverter deﬁbrillators (ICDs) and car-
diac resynchronization therapy devices (CRT-D/P) implants. On the
basis of Eucomed data, 395,000 pacemakers (PM) and 62,000 ICDs
were implanted in European countries, included in the Eucomed
survey, during 2009. But as several countries are missing in the
survey, real data of total implantation rate in European Commu-
nity in 2009 reached the number of almost 500,000 PM and more
than 71,000 ICDs [3,4]. If we look at data coming from a worldwide
survey, more than 1 million PM and 300,000 ICDs were implanted
only in the 2009 all over the globe [5], with an annual increase of
CIEDs implants which is still today around 5% [6]. Besides such a
huge increase of the number of patients wearing CIEDs, we are
witness of a wide and unstoppable proliferation of technology
generating electromagnetic signals. Thus, more and more tools
and instruments for everyday use can create electromagnetic
interference (EMI) potentially able to interact with CIEDs' normal
functioning.
We should remind that human safety exposure standards for
transmitters are actually based upon average power and biological
effects (such as tissue heating). As a result, emitters are allowed to
produce pulsed signals with peak power that greatly exceeds limits
compatible with implantable device susceptibility. Furthermore,
new indications for treatment with CIEDs results in younger
patients returning to industrial worksites. Therefore, today as
yesterday, EMI still represents a real challenge to PM and ICD
manufacturers. Such a challenge takes place both in a medical
environment as in a non-medical one and physicians caring for
patients with CIEDs should be aware of potential sources of EMI and
of appropriate management strategies, in both these scenarios.
1.1. Minimizing the effects of EMI
The potential effect of an electromagnetic ﬁeld on an implan-
table device depends on the type of the device (single/dual
chamber, PM, ICD, old/new generation, unipolar/bipolar lead)
and on the type of electromagnetic source. The clinical impact of
the interaction depends, instead, mainly on patient characteristics
(PM dependent/non-dependent patient) [7].
The ﬁrst and more important response to this emerging
problem came, already since the 1980s, from the manufacturers
who improved leads and devices safety and performance, signiﬁ-
cantly reducing the inﬂuence of electromagnetic exposure on the
correct function of PM and ICDs. Modern pacing systems have
evolved in various ways to decrease susceptibility to potential EMI.
First very handy and thinner bipolar leads were developed so that,
right now, all over the world, bipolar leads represent the current
standard, thus reducing the “antenna” effect and the oversensing
phenomenon of external electo-magnetic signals. Afterwards
industries produced more and more protected devices, with
hermetically sealed titanium shield housing or stainless steel cases
surrounding circuitries specially designed with “bandpass ﬁlters”,
to ﬁlter out signals outside the narrow range of cardiac depolar-
ization frequencies (10–50 Hz). Active bandpass ﬁlters have some
important features: they are physically very small; they are only
effective for very small amplitude signals; moreover they are
limited to relatively low frequencies and can create very sharp
ﬁlter edges to discriminate biological signals. Furthermore signalswithin the cardiac depolarization frequency range are ampliﬁed in
order to not reduce sensing capability. Finally several speciﬁc
algorithms, able to discriminate true intracardiac signals and
noises, have been developed. Noise sampling periods, for instance,
may further reduce the risk of inappropriate inhibition or trigger-
ing due to environmental signals. Signals detected during the
ventricular refractory period, for example, are regarded as noise.
Furthermore, in the presence of a strong EMI, pulse generator
often reverts to a ﬁxed backup rate, avoiding deactivation. In
certain conditions, in fact, conversion to asynchronous pacing is a
clinically acceptable alternative to inhibition.
Therefore, the risk of life-threatening arrhythmias, due to
asynchronous ventricular pacing during a vulnerable period, is a
quite uncommon event. The newest generations of devices are
equipped also with “feed-through ﬁlters” (Fig. 1) to enhance
insulation of cardiac devices, especially from high-frequency noise
in the kilohertz, megahertz and gigahertz range (Fig. 2).
Although new technology trends are aimed towards developing
smaller and long lasting devices, manufacturers also need to follow
some design constraints on PM and ICD. For example small size is
highly desirable by patients and physicians for comfort and appear-
ance; however, it limits the size and number of components and
limits the capability to control EMI indeed. At the same time, the
power used to mitigate EMI reduces the life or increases the battery
size of the device. Therefore, interference control often competes
with newer features of CIEDs and needs to deal, for example, with
the increased need for memory and data recovery, with the device-
based and lead-based sensors for monitoring and algorithm control,
with the new high frequency (RF) telemetry (4400 MHz) and ﬁnally
with an increasing complexity of implanted lead wire systems.
In conclusion, even though the technology for protection and
insulation of CIEDs has been so much improved, adverse events
related to EMI in CIEDs patients may still occur and both patients
and doctors must be aware of them and take the correct and
adequate precautions and preventive measures in every risky
situation. In addition emitter manufacturers should be encouraged
to read the pacemaker and ICD EMC standards and work with the
pacemaker/ICD industry in order to design their devices to avoid
pacemaker/ICD bandpass.1.2. The potential effects of EMI on devices' function
The protection given by the algorithms, available on the latest
generations of devices, depends on the duration of EMI sourcing.
A prolonged sensing of EMI will start one of the protection
Fig. 2. Example of passive EMI ﬁlter performance.
Fig. 3. Asystole in PM-dependent patient induced by EMI oversensing.
Table 1
Potential pacemaker response to EMI.
 Sensing/pacing inhibition.
 Noise reversion to asynchronous pacing.
 Tracking, for dual chamber devices.
 Rate changes within programmed rate limits, for rate adaptive devices.
 Activation of the reed switch (asynchronous pacing).
 Extreme case, but very unlikely: microprocessor reset.
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delay their activation. In case the algorithms does not work
appropriately, because of deactivation or intermittent sensing,
EMI could be sensed as an intrinsic ventricular activity driving to
an oversensing event and inhibition of pacing, which in a
pacemaker-dependent patient could result in a dangerous asystole
(Fig. 3) (Table 1). If the oversensing related to EMI should be in the
ventricular channel of an ICD, an erroneous detection of ventri-
cular tachycardia or ﬁbrillation could be present leading to an
inappropriate ICD therapy (Figs. 4 and 5) (Table 2). The response to
EMI-induced oversensing in the atrial channel of PM and ICDs may
be inhibition of atrial pacing, if the device is programmed in AAI or
DDD modes, or fast ventricular pacing (at the maximum tracking
rate) if the device is programmed to initiate atrio-ventrocular
interval (AV) in response to atrial signals (DDD or VDD modes).
Furthermore if the automatic mode switch algorithms are acti-
vated, they may be initiated by the atrial oversensing, changing
pacing modality from DDD to DDI (Fig. 6).
In case of a prolonged exposure to a strong electromagnetic ﬁeld,
devices may also identify it as EMI and switch in the “power-on
reset” mode which is a safety mode available for most of the
devices. Another possible response of CIEDs to EMI may be the
activation of the magnet response, which is different for each
manufacturer but in the majority of cases results in asynchronous
pacing for PM and turning off tachycardia therapies in ICDs. Besides
the speciﬁc algorithms, which equip the modern devices in order to
protect CIEDs function from deleterious effects of EMI, it is also veryimportant to know the correct and complete information of the
patients concerning the potential sources of EMI and the related
risks to them. Patients wearing CIEDs should be aware of avoiding
EMI sources or at least limiting as more as possible the exposure,
maintaining the largest distance and the shortest time as possible.
Such a simple but essential caution may be the most important
action against EMI related risks for CIEDs patients, especially out-
side of the hospital, for the non-medical sources of EMI.
1.3. Potential sources of EMI
Our world is more and more a technological one. Modern age is
the age of electronics and digital innovation and just in the last 20
years a plenty of electronic instruments, tools, devices and
machines of every kind and for every need have spread out
invading our daily lives. Following this unstoppable “electronic
tsunami”, new powerful emitters and electromagnetic sources
exploded as well, and this phenomenon is not limited in speciﬁc
professional and industrial environments but most of all regards
our private lives. Even though common household appliances,
such as microwaves ovens, televisions or computers, do not
interact with CIEDs, we still deal with plenty of potential EMI
sources in most of our daily actions. Furthermore more and more
medical procedures are based on electromagnetic ﬁelds, such as
radio-frequency (RF) ablation, magnetic resonance imaging (MRI),
lithotripsy, diathermy, harmonic scalpels and devices used in-
home or public as automatic external deﬁbrillators (AEDs), bone
growth stimulators, etc. Emitters may be intentional, as cell
phones, or unintentional, for example electric shavers (Table 3).
The main factors concerning emitters that we have to consider are frequency of the emitter;
 modulation up to several hundred Hz;
 power;
 proximity to the patient;
 duration of exposure;
 coupling factors.
Fig. 5. Inappropriate shock delivery in ICD patient due to EMI.
Table 2
Potential ICD response to EMI.
 Oversensing that manifests itself as: inhibition (missed pacing beats), and
potential inappropriate delivery of therapy.
 Tracking, for dual chamber devices.
 Undersensing an arrhythmia.
 Current induced into the lead system, that can trigger an arrhythmia.
 Reed switch activation (suspends detection).
 Extreme case, but very unlikely: microprocessor reset.
Fig. 4. Inappropriate detection of VF in ICD patient due to EMI.
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2.1. Mobile phones
Since the ﬁrst years of their massive introduction among the
population, researchers studied the potential interaction of mobile
phones with CIEDs. First reports in vitro and in vivo showed
various effects of electromagnetic ﬁeld by cellular phones on
CIEDs, ranging from oversensing and inhibition of pacing, ventri-
cular tracking to high rate or switch to asynchronous pacing [8,9].
Since the ﬁrst studies it was clear that GSM (Global system
Comunication), using frequencies between 900 and 2100 MHz,
higher power and digital signals, was able to arise most EMI
interferences with CIEDs compared to the analogical signals, at
800 MHz frequency, used in Unites States [8].As GSM covers actually more than 80% of the network market,
following these ﬁndings, CIEDs' manufacturers equipped new
generation devices with special ﬁlters reducing signiﬁcantly the
risk of interactions between CIEDs and mobile phones. In a in vivo
study, enrolling 679 patients wearing new generation pacemakers,
it was shown that when bipolar leads were used and a nominal
sensitivity value was programmed, interactions between PM and
mobile phones were recorded only in the 0.3% of patients.
Furthermore authors observed that interferences were present
only during the ringing phase, when the mobile phone was placed
less than 10 cm from the generator. Finally a higher rate of
interactions was recorded in the ventricular channel, even if this
ﬁnding was probably due to the larger number of ventricular leads
compared to atrial ones in the population studied, due to single
chamber VVI devices [10].
Also concerning the interactions between ICDs and mobile
phones, investigators found that no signiﬁcant interactions with
ICDs was provoked by the use of cell phones, even when the cell
phone overlaid the device [11]. Only a loss of telemetry during
communication between the ICD and the programming head was
reported when cell phone was close to the ICD [12].
Looking at the results of all the studies performed to establish
the safety of using mobile phones in the presence of CIEDs, we can
summarize that the incidence of interference is very low and
limited to the case the telephone is placed directly over the
pacemaker itself. Finally, even in case of recorded electromagnetic
interaction, no clinically signiﬁcant events were ever reported [13].
So we can conclude that the use of mobile phones is safe for
patients wearing CIEDs and is enough for the physicians to
Table 3
Potential sources of EMI.
 Cellular telephones.
 Digital music players.
 Portable headphones and neodymium magnets.
 Electronic article surveillance (EAS) systems.
 Metal detectors.
 Tasers.
 Slot Machines.
 Power lines and equipment that generate electric and magnetic ﬁelds at 60 and
50 Hz.
 Medical procedures: electrocautery, lithotripsy, diathermy, external
deﬁbrillation, MRI
Fig. 6. In presence of a very high electric ﬁeld the PM senses it and wrongly detects an atrial arrhythmia.
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and to avoid to keep cell phone in the pocket just in front of the
generator [14].
2.2. Digital music players
Due to their increasing utilization, the interaction between
digital music players and CIEDs have been widely evaluated in the
last years. Thaker et al. studied 54 patients exposed for 1 min to
different types of iPod, for a total number of 162 tests, both in the
presence of the telemetry wand and without the wand. The
authors reported telemetry interference in the 36.4% of tests but
no evidence of direct interference after the telemetry wand was
removed [15]. Similar ﬁndings have been reported by Chiu et al.
[16], who showed telemetry interference with the devices' pro-
grammer, in 16% of 67 patients exposed to digital music players
but, again, no changes in CIEDs function. We can conclude, indeed,
that digital music players do not affect pacemakers and implan-
table cardioverter-deﬁbrillators function, but can cause only inter-
ference with interrogation telemetry [17].
2.3. Portable headphones and neodymium magnets.
Opposite ﬁndings have been reported when evaluating porta-
ble headphones, as most of them use neodymium which is a
powerful magnetic substance. It has been showed that, when
portable headphones are within 3 cm of the CIEDs, they can
produce EMI and directly interact with the devices [18]. The
strength of the magnetic ﬁeld, in fact, decreases as the distance
from the magnets increases. Another factor conditioning the
potential interference is the size of the magnets, so that the in-
ear headphones, using very small magnets, do not interact with
the devices. The same neodymium magnets are used commonly in
jewelry and clothing as claps and few reports of unexpected
erratic behavior of implantable cardioverter-deﬁbrillator related
to the magnetic ﬁeld generated by them have been published in
literature [19,20].In summary portable headphones are generally safe for
patients wearing CIEDs, but it should be anyway recommended
to them to keep the headphones far from the pulse generator.
2.4. Metal detectors.
Another common potential source of interference with CIEDs
are the metal detectors. The main application for metal detectors
is the security one, especially in the airports security check points.
Many studies in the last decade evaluated the interaction between
CIEDs and the magnetic ﬁeld provided by metal detectors, espe-
cially by the walk-through type, which have considerably higher
magnetic-ﬁeld strength than the handheld ones [21].
Kolb et al. [22] studied 348 consecutive patients (200 pace-
makers and 148 ICDs) underwent a short exposure time, into the
magnetic ﬁeld of an airport metal detector. A majority of
the pacemakers were dual-chamber (n¼140), although investiga-
tors also examined patients with single-chamber and biventricular
devices. Among the ICDs, two thirds of the devices were single-
chamber, 46 were dual-chamber, and four were cardiac resyn-
chronization devices. Investigators set up a standard metal detec-
tor in their clinic and then studied the patients as they came in for
routine checks of their ICDs and pacemakers. Testing a worst-case
scenario in which patients would be forced to spend an excessive
amount of time within the airport metal detector, investigators
asked patients to remain 20 s within the security gate. There were
no clinically relevant outcomes reported in any of the pacemaker
patients tested. The electrical ﬁeld from the airport metal detector
did not result in any cases of atrial or ventricular oversensing, loss
of capture, pacing disturbances, or spontaneous reprogramming in
any of the pacemaker devices examined. In patients with an ICD,
the metal detector did not result in any inappropriate detection of
ventricular arrhythmias, spontaneous reprogramming of the ICD,
or temporary suspension of the device. With no adverse episodes
reported, investigators conclude that, considering a period of just a
few seconds within the electromagnetic ﬁeld for routine airport
security controls, clinically relevant interactions with pacemakers
or ICDs seem to be unlikely.
More recently Jilek et al. [23], studied a population of 209
pacemaker patients and 179 ICD recipients of different models.
The authors used two models of metal handheld detectors,
programmed at the maximal sensitivity, swiping them directly
over the cardiac apex and the can for more than 30 s (much longer
than conventional screening time, indeed). Nor changes of pro-
gramming or pacing and sensing abnormality neither other
unexpected malfunction of the devices has been reported in any
patient. Following these clear ﬁndings, the most recent Transpor-
tation Security Administration recommendations advise, but not
require, patients wearing CIEDs to alert security personnel con-
cerning the implanted device. Even if metal detectors, both walk-
through and hand-held ones, do not cause any interference with
the functioning of the CIEDs, they recognize the ferrous
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case a pat-down or hand search by the security ofﬁcers will be
required.2.5. Electronic surveillance devices
Since several years electronic antitheft surveillance devices are
present in almost all stores and shops. Few reports of inappropri-
ate ICD shocks due to interactions with security systems in public
and commercial environment have been reported in literature
[24–26]. A crucial issue for the potential interaction with CIEDs
seems to be, again, the time of exposure. In a study enrolling 170
patients with ICDs, exposed to 3 different surveillance systems, the
authors did not report any interaction when the exposure time
was as low as 15 seconds, but when exposure was as long as
2 minutes and the ICD within 6 in. of the gate, EMI, potentially able
to drive inappropriate therapy of the ICD, has been recorded [26].
In the same study also 25 ICD recipients were evaluated following
the same protocol and no abnormal response of any ICD with any
of the security systems has been reported [27].
Acousto-magnetic security systems pulse a magnetic ﬁeld able
to detect tags at great distances and therefore have a higher risk of
interaction with CIEDs. Among 50 pacemakers patients exposed to
such systems in a single center study, in 48 patients it was possible
to record interference, including asynchronous pacing, atrial over-
sensing and fast ventricular pacing, ventricular oversensing and
pacing inhibition. These interactions were more frequent as the
devices remained exposed longer to the security systems and were
responsible for speciﬁc symptoms in some of the patients but only
while patients were within the magnetic ﬁeld [28]. Similar
conclusions come from the results of a retrospective observational
study including 336 patients wearing ICDs during a 16 years
follow-up, without any report of inappropriate shock due to
electronic article surveillance systems exposure [29].
In conclusion, even if the risk of effective interaction of CIEDs
with surveillance systems is extremely low, patients wearing
implantable devices should avoid to tarry inside or be close to
the security gates, in public and commercial environment.2.6. Other non-medical sources
Besides these more frequent EMI sources we described above,
other less common potential causes of electromagnetic ﬁelds are
present in the non-medical environment. Few case reports about
the effects of Tasers' use in CIEDs patients are published in
literature [30,31]. Tasers are weapons, used by police ofﬁcers in
many countries, that shoots tethered probes able to deliver short
pulses of current with a peak voltage up to 1500 V. In one case ICD
sensed the pulses of current delivered by the taser as ventricular
ﬁbrillation, charged the capacitors but did not deliver the shock
due to interruption of the current ﬂow [32].
Also slot machines have been reported to be responsible
for inappropriate ICD shocks due to EMI in 4 patients playing
the slots [33].
Furthermore, for many other electronic tools, reports of inter-
actions with CIEDs are not available; this does not mean that there
is no risk of interaction at all. Thus many manufacturers of
household tools, for example, provide general recommendations
for patients wearing CIEDs so as to keep as greater distance as
possible from the tool motor and the pulse generator. Moreover
newer and newer electronic tools, potentially able to interact with
CIEDs, are continuously launched in the market; therefore it is a
must for physicians to always consider the risk of EMI and to give
appropriate recommendations to their PMK/ICDs patients.3. Medical environment
3.1. MRI in CIEDs patients
Magnetic resonance imaging (MRI) is the imaging modality of
choice in many clinical situations as a result of its ability to provide
an excellent soft tissue contrast without radiation or the use of
iodinated contrast media. The worldwide use of both MRI and
CIEDs has increased signiﬁcantly in the last years and a signiﬁcant
number of device-implanted patients likely will need an MRI over
the course of the lifetime of their device.
Traditionally, MRI has been contraindicated in patients with
cardiac pacemakers or ICD because of the potentially life-
threatening interactions between the magnetic ﬁelds or the
high-frequency (HF) pulses and the respective device. For this
reason, in recent years attention has turned to devices that are
speciﬁcally designed to be safe in the MRI. Previous experience
and initial data suggest that this technology is safe and may allow
pacemaker patients to undergo MRI [34–38] and in early 2011, the
US Food and Drug Administration approved the ﬁrst cardiac
pacemaker designed to be used safely during MRI examinations.
Although some studies demonstrated that, given appropriate
precautions, MRI can be safely performed in ICD patients, the
presence of an ICD is still considered a strong contraindication for
MRI [39,40], and most ICD patients are denied from MRI.
There are several risks of performing MRI in CIEDs patients,
which are different from those caused by other EMI sources.
During MRI, in fact, static magnetic, magnetic pulsating gradient
and radio-frequency ﬁelds generate strong forces which might
interfere with the normal pacing function and have the potential
to induce several hazardous effects.
The interactions of MRI with CIEDs can be classiﬁed as follows
according to physical interactions and effects on the device or/
patient:(a) Static magnetic ﬁeld
 The patient is subjected to an intense magnetic ﬁeld that
could produce mechanical forces on ferromagnetic compo-
nents, causing mechanical or functional disorder of the
device.
 Unpredictable magnetic sensor activation, reed-switching
closure, drive to an inhibition of stimulation, or to a
reversion of programming asynchronously.
 Changes in electrocardiograms.
(b) Modulated Radio Frequency (RF) Field
 Heating of cardiac tissue adjacent to lead electrodes: a
current ﬂow through the lead could result in overheating
and thermal damage of cardiac tissue adjacent to lead
electrodes which can cause changes in sensing and thresh-
old values or myocardial perforation.
 Possible induction of life-threatening arrhythmias (very
rare).
 Pacemaker reprogramming or reset.
 RF interactions with the device (over- and under-sensing).(c) Gradient Magnetic Field
 Possible induction of life-threatening arrhythmias (unlikely
in bipolar mode).
 Induced voltages on leads cause over- and under-sensing.(d) Combined Field Effects
 Alteration of device function because of EMI.
 Mechanical forces (vibration).
 Electronic reset of device.
 Damage to pacemaker/ICD and/or leads.These potentially harmful effects have been mainly identiﬁed
in older pacing technology. During the last decade, a number of
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be safely performed in patients with implanted pacemakers in
carefully selected clinical circumstances when appropriate strate-
gies are used [41–44]. Although distinctly different, PM and ICDs
share similar electronic components and thus, to some extent,
their response to the electromagnetic interference (EMI) might be
similar. However, ICDs have more complex technology than pace-
makers and have larger capacitors and batteries. As a result, the
magnetic forces are greater, and they are theoretically more prone
to electromagnetic and mechanical interference. In addition, in
comparison with PM patients ICD patients have a higher-risk
proﬁle; therefore safety issues in imaging of ICD patients are more
complex.
In recent years, there have been small to modestly sized human
studies that have reported on the relative safety of MR examina-
tion in the setting of ICD patients [44–47]. These cases demon-
strated a favorable risk to beneﬁt ratio using tailored MRI
scanning, pre- and post-scan reprogramming and monitoring
during scanning. Nevertheless we should recall that a limited
number of MRI scans have been reported on ICD patients in the
medical literature. Such a controversy concerning safety of scan-
ning patients with such devices cannot be settled just because a
few ICD patients have safely undergone MRI. There is a need for
safe MRI conditional ICD, which is both real and urgent. It is
important to quote Professor Gimbel's editorial comment [48] on
the study of Martin et al. [42] “…We believe strongly that device
manufacturers must design their implantables as MR-compatible
“from the ground up” rather than depend on a series of intrepid
patients and physicians engaged in post-manufacturing experi-
ments. Patients and the implanting community should expect
nothing less than devices that are MR-safe by design, not by
chance.”. Of note, Biotronik has recently developed an ICD compa-
tible with MRI, which has just been market-released in Europe.
However, there are no published studies with this new currently
available system. Although this system does not allowMRI scans of
the chest, the technology is unquestionably developing fast and
some current technical limitations are already being resolved.
3.2. Special precautions during MRI in ICD patients
There are some important issues to be considered about
potential interactions of MRI scan with ICDs (Table 4). The exam
should be performed only in experienced centers with close
cooperation between the radiologists and electrophysiologists
and, to minimize radiofrequency-related lead heating, speciﬁc
absorption rate should not exceed the value of 2 W/kg [49].
Devices should be reprogrammed pre-MRI to avoid competitive
pacing and potential pro-arrhythmia with deactivation of therapy
delivery. In particular, the ICD should be reprogrammed to VVITable 4
Special precautions during MRI in ICD patients.
Pre-MRI
Complete ICD check
Deactivation of therapy delivery
VVI pacing with the lowest possible lower rate limit
Asynchronous pacing in pacemaker-dependent patients
During MRI
Presence of an electrophysiologist
Continuous monitoring of ECG and pulse oximetry
Limitation of speciﬁc absorption rate values
Post-MRI
Complete ICD check and reprogramming
Consider DFT to ensure integrity of the ICD system.
ICD follow-up 5–6 weeks after MRIpacing with the lowest possible lower rate limit and an asynchro-
nous mode should be selected in pacemaker-dependent patients.
Since reed switch closure is not reliable during MRI scans [50],
deactivation of therapy delivery should be performed before the
exam to minimize the risk of inappropriate therapy delivery.
Another important interaction is an electrical reset leading to an
unintended reprogramming of the ICD with reactivation of ven-
tricular tachyarrhythmia therapy options. This can lead to inap-
propriate shocks during MRI scans. We also recommend the
availability of full resuscitation facilities and continuous monitor-
ing of ECG and pulse oximetry during the MRI exam. A complete
ICD check is required immediately after MRI to evaluate and
ensure the integrity of the entire ICD system. To exclude potential
late effects, we also recommend to check again the integrity of the
system 5–6 weeks after MRI,
Controversies exist with regard to the utility of deﬁbrillation
threshold testing (DFTT) to ensure integrity of the ICD system
after MRI. Correct sensing of ventricular signals during VF may
indicate that signiﬁcant myocardial damage at the lead tip or
damage to the ICD lead and the ICD device is unlikely. Levine et al.,
on behalf of the American Heart Association, recommends
DFTT post-MRI [40]. In contrast, the European Society of Cardiol-
ogy does not support the routine use of DFTT/DSMT post-MRI
believing the risk attributed to DFTT/DSMT may outweigh any
potential beneﬁt [39]. More recently the results of a study on 38
patients undergoing MRI suggest that routine DFTT/DSMT post-
MRI may not be necessary [47]. Our opinion is that in the presence
of any modiﬁcation of ICD electrical parameters post-MRI, the
DFTT should be mandatory; other patients should be considered
on a case-by-case basis
3.3. Electrocautery devices for surgical procedures
High frequency signals generated by electrocautery may inter-
fere with implanted ICD devices. Electrocautery is often used to
minimize blood loss during surgery and to ablate tissue. The probe
used to perform electrocautery generates a high frequency elec-
trical current that may result in oversensing, independent of
unipolar or bipolar coagulation mode that is used. This over-
sensing leads to a pacemaker inhibition or false detection of
ventricular tachyarrhythmias (Fig. 7) resulting in inappropriate
shock therapy [51]. For this reason, the use of electrocautery is
contraindicated when the automatic tachycardia response of the
patient's ICD is enabled.
Due to these potentially harmful effects, there are some important
precautions to consider whenever electrocautery is used with ICD
patients. Device should be reprogrammed before surgery with
deactivation of therapy delivery and an asynchronous mode should
be selected in pacemaker-dependent patients. This detection of ICDs
may be temporarily inactivated placing a magnet over the device;
this suspends tachyarrhythmia detection and response as long as the
magnet is held in place over the device. The patients should be
closely monitored during the intervention, using short and inter-
mittent bursts at the lowest feasible energy levels, avoiding direct
contact between the electrocautery probe and the ICD system. We
also recommend the use of a bipolar electrocautery systemwhenever
possible [52], with the ground plate positioned as far as possible from
the implanted system. Of note, electrocautery used in the direct
vicinity of an ICD could potentially damage the device; therefore, in
these cases, post-procedural ICD check may be considered to
evaluate the integrity of the ICD system.
3.4. Potential interactions with radiation therapy
Many sources of ionizing radiation are capable of interfering
with an implanted device, including those used for the treatment
Fig. 7. EMI during electrosurgery in a CRT-D/PM-dependent patient leading to both, pacing inhibition with asystole and erroneous VF detection.
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active seeds, and betatrons. Diagnostic radiation generally does
not have any signiﬁcant adverse effect on ICDs. On the other hand,
ionizing radiation may adversely affect ICDs through electromag-
netic interference or through its effects on the devices' metal oxide
semiconductors (CMOS) components [53]. Severe malfunctions
have been reported in ICDs exposed to radiations. In particular,
radiation adversely alters CMOS technology and the mechanism of
failure is unpredictable, since any part of the semiconductor can be
damaged. Current approaches to treatment of ICD patients as well
as recommendations given by the manufacturers of these devices
differ considerably [54]. Reports in the literature include damage
from radiation doses as low as 10 Gy; therefore direct ICDs
radiation at therapeutic levels should be strictly avoided and
accumulated doses should generally not be allowed to exceed
5 Gy. Of note, a complete ICD check is required in short periods
during and after radiation, to evaluate and ensure the integrity of
the entire ICD system.
3.5. Electrical nerve stimulation
Transcutaneous electrical nerve stimulation (TENS) and spinal
cord stimulators may result in inappropriate inhibition or false
tachyarrhythmia detection resulting in ICD shocks. Few ICD mal-
functions have been reported in literature. TENS is commonly used
for the relief of acute and chronic musculoskeletal pain. TENS units
should be avoided in the proximity of the ICD system. In the
situation of pacemaker-dependent ICD patients TENS is not
recommended except in cases with a strong clinical indication
and in which the beneﬁts clearly outweigh the risks. There are a
few reports that have suggested that, with proper precautions,
bipolar spinal cord stimulators can be used safely in ICD patients
[55,56]. Individual testing is recommended to exclude that spinal
cord stimulation does not cause pacemaker inhibition or problems
with sensing during ventricular ﬁbrillation.4. Conclusions
In the last years we are witnessing a dramatic increase in the
number of CIEDs implanted. At the same time new emitters are
constantly entering the marketplace and more and more medical
procedures are based on electromagnetic ﬁelds as well. Therefore,
the topic of the interaction of CIEDs with the EMI is a real,
actual and challenging one. Pacemaker/ICD manufacturers areincorporating state of the art technology to make implantable
devices less susceptible to EMI. However, patients and emitter
manufacturers should be aware that limitations exist and that
there is not complete immunity to EMI. The pacemaker industry is
working with regulatory bodies and emitter manufacturers to
educate patients and physicians and develop appropriate warn-
ings, when required. But Pacemaker and ICD manufacturers cannot
solve all EMI issues alone, labeling and customer education is
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